Efficiency of treatment and prevention of complications of parodontitis in patients with metabolic syndrome efficiency of treatment and prevention of complications of parodontitis in patients with metabolic syndrome by Pyndus, T. A.
 170 
Pyndus T. A. Efficiency of treatment and prevention of complications of parodontitis in patients with metabolic syndrome efficiency 
of treatment and prevention of complications of parodontitis in patients with metabolic syndrome. Journal of Education, Health and 
Sport. 2017;7(10):170-176. eISSN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.1079893 
http://ojs.ukw.edu.pl/index.php/johs/article/view/5089 
 
 
 
 
The journal has had 7 points in Ministry of Science and Higher Education parametric evaluation. Part B item 1223 (26.01.2017). 
1223 Journal of Education, Health and Sport eISSN 2391-8306 7 
© The Authors 2017; 
This article is published with open access at Licensee Open Journal Systems of Kazimierz Wielki University in Bydgoszcz, Poland  
Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, 
provided the original author(s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License 
(http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited. 
This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted, non commercial 
use, distribution and reproduction in any medium, provided the work is properly cited.  
The authors declare that there is no conflict of interests regarding the publication of this paper. 
Received: 10.10.2017. Revised: 19.10.2017. Accepted: 20.10.2017. 
 
DC 616-08-084+616.314.17-008.1:616.699.465.623 
 
EFFICIENCY OF TREATMENT AND PREVENTION OF COMPLICATIONS OF 
PARODONTITIS IN PATIENTS WITH METABOLIC SYNDROME 
EFFICIENCY OF TREATMENT AND PREVENTION OF COMPLICATIONS OF 
PARODONTITIS IN PATIENTS WITH METABOLIC SYNDROME 
 
T. A. Pyndus  
 
Lviv National Medical University 
 
Abstract 
Introduction. Given the increasing prevalence of metabolic syndrome among the 
population, the search for ways to treat and prevent major dental diseases in this somatic 
pathology is of great importance. 
Purpose of the study. The purpose of this work was to evaluate the effectiveness of 
the developed treatment and prophylaxis complex in patients with generalized parodontitis in 
combination with metabolic syndrome. 
Materials and methods. In in-depth studies, 53 people aged 30-55 years with a 
diagnosis of "chronic generalized parodontitis" and "metabolic syndrome" took part. The 
main group of patients in addition to basic therapy received a developed, pathogenetically 
substantiated therapeutic and prophylactic complex, 2 times a year. Evaluation of the dental 
status of patients was performed in the initial state, after the first course of prevention at 6 
months and in a year. 
Results. Conclusions. The high clinical effectiveness of the developed complex, 
including preparations of antibacterial and anti-inflammatory action, reducing cholesterol, 
 171 
reducing vascular permeability, normalizing metabolism, blood circulation and fat 
metabolism, enhancing immunity and resistance of the organism is shown. 
Key words: chronic generalized parodontitis, metabolic syndrome, dental status, 
level of oral hygiene. 
 
ЭФФЕКТИВНОСТЬ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ ОСЛОЖНЕНИЙ 
ПАРОДОНТИТА У ПАЦИЕНТОВ С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ 
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Реферат 
Проведение лечебно-профилактических мероприятий пациентов с хроническим 
генерализованным пародонтитом на фоне метаболического синдрома показало 
высокую клиническую эффективность разработанного комплекса, включавшего 
препараты антибактериального и противовоспалительного действия, снижающие 
холестерин, уменьшающие проницаемость сосудов, нормализующие обмен веществ, 
циркуляцию крови и жировой обмен, усиливающие иммунитет и резистентность 
организма. При этом существенно улучшились индексы РМА %, Шиллера-Писарева, 
кровоточивости, состояние гигиены полости рта, а кариеспрофилактическая 
эффективность составила 18,1 % за год наблюдений. 
Ключевые слова: хронический генерализованный пародонтит, 
метаболический синдром, стоматологический статус, уровень гигиены полости 
рта. 
 
Metabolic syndrome (MetS) leads to pathological changes that are observed in almost 
all organs and tissues of the body, including in the oral cavity [1-5]. MetS is accompanied by 
disorders, primarily fat and carbohydrate metabolism, as well as a violation of the vascular 
endothelium. 
Given the increasing prevalence of MetS among the population at present, the search 
for ways to treat and prevent major dental diseases in this somatic pathology is of great 
importance. 
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The aim of this work was to evaluate the effectiveness of the developed treatment and 
prophylaxis complex in patients with chronic generalized parodontitis (CGP) in combination 
with MetS. 
Materials and methods. From the pre-examined patients diagnosed with "metabolic 
syndrome" 53 people of the age of 30-55 years with chronic generalized parodontitis and with 
violation, mainly of fat and carbohydrate metabolism were selected. The comparison group 
(25 people) received basic therapy (oral sanitation and occupational hygiene), and the main 
group of patients (28 persons) in addition to basic therapy received 2 times a year, the 
treatment and prophylactic complex that pathogenetically grounded (molecular- genetic and 
epigenetic evaluation of disorders in a number of genes in patients with CGP in the 
background of MetS) and pre-approved in rats given in Table 1. 
Table 1 
Treatment-and-prophylactic complex of chronic generalized parodontitis on the 
background of metabolic syndrome 
Used medication Dosage 
Terms of 
application 
Mechanism of action 
1 2 3 4 
«Chlorophylline» 
(pills) 
1 pill 3 times 
per day (0.8g) 
7 days 
antibacterial, antiseptic, anti-
inflammatory, reduces 
cholesterol, reduces vascular 
permeability 
«Laktusan»  
(syrup) 
2 tea spoon 2 
times in a day 
10 days 
prebiotic - normalizes 
metabolism, intestinal 
microflora, enhances immunity 
and resistance of the body 
«Oxiphite Map» 
5 drops in 1 
tablespoon of 
water, 2 times 
a day with 
food 
1 month 
regulates lipid metabolism, 
provides tissue with oxygen, 
improves metabolism and 
circulation, removes toxins 
from the body 
«Sera aktiv» 
1 pill 3 times a 
day with food 
1 month 
anti-inflammatory, 
microelement with vitamins B, 
D, E - improves blood 
circulation, normalizes fat 
metabolism, assimilation of 
fats and proteins 
«Kvertulidone»  
(gel) 
Applique for 
the night 
1 month 
increases local nonspecific 
resistance 
«Chicory»  
(эликсир) 
1 teaspoon per 
¼ cup water 
1 month regulates microbiocenosis 
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1 2 3 4 
«Lacalut flora» 
(Toothpaste) 
In the morning within 1 year anti-inflammatory effect 
«Imidzh» 
(Toothpaste) 
In the evening within 1 year effect of micron purification 
 
Evaluation of the dental status of patients was performed in the initial state, after the 
first course of prevention, at 6 months and in a year. At the same time, the state of hard tissues 
of teeth (indices DMFT and tartar), oral hygiene (Silness-Loe and Stallard indices) and 
parodontal tissues (PMA%, bleeding indexes, Schiller-Pisarev test, depth of parodontal 
pockets) were evaluated [6]. 
Results. Table 2 shows the results of the evaluation of the parodontal status of patients 
with CGP and MetS. 
Table 2 
Condition of parodontal tissues in patients with chronic generalized parodontitis with 
metabolic syndrome in the process of using the treatment-and-prophylactic complex,  
M ± m 
Indicators  
Terms РМА % 
Bleeding, 
scores 
Sample of Sh-P, 
scores 
Parodontal 
pocket, mm 
Main group, n=28 
before treatment 
39,71 
±6,21 
p>0,1 
1,88 
±0,35 
p>0,1 
1,93 
±0,28 
p>0,1 
1,8 
±0,40 
p>0,1 
after treatment 
4,88 
±0,75 
p<0,001 
0,6 
±0,09 
p=0,05 
0,2 
±0,03 
p<0,001 
1,7 
±0,40 
p>0,1 
in 6 months 
5,03 
±0,70 
P<0,001 
0,71 
±0,10 
P<0,01 
0,21 
±0,03 
p<0,001 
1,79 
±0,40 
p>0,1 
after 1 year 
5,38 
±0,90 
p<0,001 
0,76 
±0,10 
p<0,001 
0,23 
±0,003 
p<0,001 
1,81 
±0,40 
p>0,1 
Comparison group, n = 25 
before treatment 
40,33 
±7,35 
1,93 
±0,30 
2,03 
±0,30 
1,98 
±0,50 
after treatment 
29,86 
±4,21 
1,29 
±0,35 
1,59 
±0,21 
1,98 
±0,40 
in 6 months 
35,72 
±5,91 
2,15 
±0,39 
1,74 
±0,20 
2,01 
±0,40 
after 1 year 
45,49 
±6,21 
2,74 
±0,41 
2,29 
±0,30 
2,19 
±0,50 
Note: p is an indicator of the reliability of differences from the comparison group. 
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After the first treatment-and-prophylactic course, the PMA% index decreased 8.2 
times and remained practically at this level during the year of observation. At the same time, 
the preventive effect for 6 months was 87.3%, and for the year - 86.45%. In the comparison 
group, the PMA% index, after treatment, decreased by 25.9%, but after 6 months it 
deteriorated by 19.6% and the prophylactic effect was only 11.4%. During the year of 
observation, the PMA index in the comparison group deteriorated (Table 2). 
The bleeding Index in the main group of patients after the first course of prevention 
decreased more than 3 times, while in the comparison group - only 1.5 times. In the main 
group of patients, the bleeding Index during the year of observations did not change 
significantly, and in the comparison group it was 1.42 times higher than in the initial state. 
The prophylactic effect of the developed complex in the main group relative to the initial state 
was 59.6% in a year  
The indicator of the Schiller-Pisarev test (Sh-P) after the first course of treatment 
decreased 9.6 times and remained practically unchanged during the year of observation. The 
preventive effect in this case was 88%. At the same time, in the comparison group, the Sh-P 
index after the first course of treatment decreased by 21.7%, and then increased and after a 
year it exceeded the initial value by 1.13 times. 
Parodontal pocket in the average for the main group for the year of observations has 
not changed, and in the comparison group has unreliably increased. 
The results of assessing the condition of hard tissues of teeth and the level of oral 
hygiene in the process of treatment and prophylactic measures are given in Table 3. 
From the data presented, it can be seen that in the main group of patients, the increase 
in caries by DMFT index was 2.1 teeth, while in the comparison group the gain was 2.48 
teeth, and the reduction of tooth caries for the year of observation was 18.1%.  
The index of oral hygiene Silness-Loe after the first treatment course was reduced 
more than 3 times and remained at this level after 6 months and a year later. The preventive 
effect was 61.7%. In the comparison group after the first course of treatment, the S-L index 
decreased by 1.72 times, but later it increased all the time and a year later was 1.1 times 
greater than in the initial state.  
The Stallard hygiene index in the main group for the year of observation decreased by 
1.39 times and the caries prophylaxis effect was 62.3%. At the same time, in the comparison 
group, after a year of observations, it was 1.15 times greater than in the initial state. 
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Table 3 
The state of hard tissues of teeth and oral hygiene in patients with chronic generalized 
parodontitis and metabolic syndrome in the process of using the treatment and 
prophylactic complex, M ± m 
Indicators  
Terms 
DMFT, 
scores 
Silness-
Loe, 
scores 
Stallard, 
scores 
Tartar, 
scores 
Condition of hygiene of the oral cavity 
(%) 
good satisfactory unsatisfactory bad 
Main group, n=28 
before 
treatment 
13,89 
±1,41 
p>0,1 
1,54 
±0,19 
p>0,1 
1,91 
±0,21 
p>0,1 
1,96 
±0,31 
p>0,1 
17,9 28,6 46,4 7,1 
after 
treatment 
13,89 
±1,35 
p>0,1 
0,5 
±0,08 
p<0,01 
0,6 
±0,08 
p<0,01 
1,2 
±0,16 
p>0,1 
25 67,9 7,1 - 
in 6 
months 
15,1 
±1,71 
p>0,1 
0,52 
±0,07 
p<0,001 
0,69 
±0,09 
p<0,001 
1,49 
±0,19 
p>0,1 
25 64,3 10,7 - 
after 1 
year 
16,0 
±1,85 
p>0,1 
0,59 
±0,08 
p<0,001 
0,72 
±0,09 
з<0,001 
1,67 
±0,17 
p>0,1 
25,4 62.6 12 - 
Comparison group, n = 25 
before 
treatment 
14,82 
±1,70 
1,58 
±0,21 
1,89 
±0,23 
2,01 
±0,29 
16 28 48 8 
after 
treatment 
14,82 
±1,65 
0,92 
±0,02 
1,24 
±0,15 
1,29 
±0,16 
20 48 32 - 
in 6 
months 
16,48 
±1,90 
1,31 
±0,15 
1,86 
±0,21 
1,91 
±0,30 
16 48 36 - 
after 1 
year 
17,3 
±1,99 
1,72 
±0,20 
2,17 
±0,25 
2,12 
±0,30 
16 48 36 - 
Note: p is an indicator of the reliability of differences from the comparison group. 
 
The index of tartar in the main group of patients after treatment decreased by 38.7%, 
but after 6 months it increased by 24%. The prophylactic effect for 6 months of observations 
was 23.9%, and for the year - 15%. At the same time, in the comparison group after treatment, 
the index of tartar decreased by 35.8%, but after 6 months - it increased by 48%. For 6 
months from the initial condition, the preventive effect was about 5%, and for the year - was 
absent, having increased relative to the initial value by 5%.  
In the main group, the number of patients with good oral hygiene increased by 3.5%, 
while in the comparison group it did not change. The number of patients with a satisfactory 
level of hygiene increased in the main group by 47.4%, and in the comparison group - only by 
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20%, that is, 2 times less than in the main group. In addition, in the main group, the number of 
patients with unsatisfactory oral hygiene decreased by 34%, and in the comparison group - by 
12%. During the year of observations after basic therapy (in both groups) and treatment and 
prophylactic courses in the main group patients with poor oral hygiene were absent (Table 3). 
It should be noted that the effect of the developed treatment-and-prophylactic complex 
is aimed both at preventing complications of parodontal tissue diseases in patients with CGP, 
and in preventing complications and preventing the development of MetS. 
Conclusions. The treatment-and-prophylactic measures of patients with chronic 
generalized parodontitis on the background of the metabolic syndrome showed a sufficiently 
high, taking into account the age of the patients, the clinical effectiveness of the developed 
complex, including antimicrobial and anti-inflammatory drugs, reducing cholesterol, reducing 
vascular permeability, normalizing metabolism, blood circulation and fat metabolism , 
enhancing immunity and resistance of the body. At the same time, the indices of PMA%, 
Schiller-Pisarev, bleeding, the state of oral hygiene were significantly improved, and caries 
prophylactic efficacy was 18.1% for the year of observation.  
 
References 
1. Eckel R. H., Grundy S. M., Zimmet P. Z. The metabolic syndrome. Lancet. 
2005; 365:1415–28. 
2. Apoorva S. M., Sridhar N., Suchetha A. Prevalence and severity of periodontal 
disease in type 2 diabetes mellitus (noninsulin-dependent diabetes mellitus) patients in 
Bangalore city: an epidemiological study. J Indian Soc Periodontol 2013; 17:25–29 
3. Grundy S. M. Metabolic syndrome scientific statement by the American Heart 
Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc 
Biol 2005; 25:2243–2244. 
4. Orehova L. Ju., Kuchumova E. D., Barmasheva A.A. at al. Periodontal disease 
in patients with metabolic syndrome. Parodontologija. 2011: 2(59): 28-31. 
5. Morita T., Yamazaki Y., Mita A. et al. A cohort study on the association 
between periodontal disease and the development of metabolic syndrome. J Periodontol. 
2010; 81(4): 512-519. 
6. Khomenko L. O., Chaykovskyy Y. B., Smolyar N. I. at al. Terapevtychna 
stomatolohiya dytyachoho viku [Therapeutic dentistry for childhood] – Kyyiv: Knyha plyus, 
2014. 432p. 
